Building Momentum tells the stories behind Colorado’s growing reputation as a leading national and international hub for life sciences. Our 2022-2023 BioScience Colorado Magazine profiles leaders from across our community who are building new lab space, closing funding rounds, breaking barriers, advancing Colorado’s leadership in cell and gene therapy, and growing their companies after receiving state-funded grants.
The magazine also provides data on financings, clinical trials, and regulatory milestones achieved by our ecosystem. A comprehensive directory includes the companies, organizations, and institutions in our community. We designed the annual magazine in print and digital format as a resource for members and partners to share with potential investors and prospective business partners or send to out-of-state candidates for leadership positions.
Please let our team know if you need paper copies of the magazine.
Colorado BioScience Association members drive global health innovations, products, and services that improve and save lives. Their dedication and passion inspires us.
Invenux, LLC, a privately held clinical stage biopharmaceutical company, is propelling its research and clinical trials forward to treat sickle cell disease in patients from the U.S. and largely around the world. By developing a botanical medicine approach, Invenux aims to break down barriers to save and change lives for sickle cell disease patients.
Validus Cellular Therapeutics
Validus Cellular Therapeutics, Inc. is pioneering the use of cellular therapy for the treatment of drug-resistant, chronic bacterial infections. Cellular therapy approaches have been successful for oncology patients, and researchers at Colorado State University and the Anschutz Medical Campus discovered stem cells can also be activated to fight infections.
Atara Biotherapeutics is a leading allogeneic T-cell immunotherapy company pioneering the development of transformative off-the-shelf therapies for patients with serious diseases including solid tumors, hematologic cancers, and autoimmune diseases.
Greffex™ is a privately held, multi-national company that developed a novel genetic platform for the development and production of vaccines. The GREVAX™ Universal Platform delivers vaccines in a faster, more affordable, and more efficient manner in as little as four weeks.
Pathways Bioscience’s technology improves healthspan and overcomes health and wellness problems associated with aging. By use of a dietary supplement with naturally occurring plant-based ingredients, the body supports it own defense mechanisms that allow it to protect and heal itself.
ClearSight is developing innovative solutions for ophthalmologists that aim to change the standard of care for many patients. Utilizing a micropattern and patented design, the first intraocular lens ClearSight is developing aims to prevent secondary cataract. The second intraocular lens in development utilizes a novel optical system to restore youthful vision.
Zalgen Labs is making a difference for patients around the world with solutions to viral threats and neglected tropical diseases. They specialize in the design and production of superior biological molecules critical for the development and commercialization of immunotherapeutics, novel vaccines, and reliable, rapid, and affordable diagnostic platforms targeting neglected and underrepresented human infectious diseases.
GelSana Therapeutics, Inc. is fabricating next-generation wound healing hydrogels that offer faster healing with less inflammation, especially for chronic wounds such as diabetic ulcers. The GelSana team is dedicated to solving the significant and costly problem of diabetic ulcers through their unique hydrogels designed to decrease infection and improve lives of patients.
Foresight Diagnostics, an emerging leader in blood-based lymphoma disease monitoring, is transforming patient care with groundbreaking cancer surveillance technology. The Foresight team can identify patients that are cured of lymphoma during treatment, eliminating unnecessary chemotherapy and dramatically improving quality of life. Foresight does this by using the world's most sensitive cancer surveillance technology to detect cancer relapse up to 100 days sooner than current testing methods.
Exxel Pharma is a development stage company that combines world-class leadership, expert technological know-how and experience from the pharmaceutical industry to develop medicines for significant unmet medical needs. Exxel is focused on the development of small-molecule therapeutics for safe, non-addictive treatment of pain, PTSD, and substance (e.g. opioid) use disorders.
CPC is a non-profit, mission-driven Academic Research Organization (ARO) that supports all phases of clinical research. Their academically led team provides fullservice support, offering scientific oversight, full-service clinical research, and collaborative support. The impact goes beyond research and continues into community implementation through their Community Health programs.
PhosphoSolutions specializes in producing high-quality research antibodies for the neuroscience community. The company’s research antibodies provide critical information on drug effectiveness that drives scientific breakthroughs.
The Colorado Molecular Correlates Laboratory
The Colorado Molecular Correlates Laboratory is dedicated to the development and implementation of predictive, prognostic and diagnostic molecular biomarker testing that will permit selection of cancer treatments with targeted therapy allowing for the best in personalized medicine. Focusing on quality is key to the lab’s success and work to save lives.
Cerebral Therapeutics is dedicated to improving the lives of patients living with uncontrolled neurological diseases, with an initial focus on refractory epilepsy. The company is addressing chronic neurological diseases using novel and proprietary drugs administered directly to the fluid around the brain. With a newly launched Phase 2b study, Cerebral credits its mission-driven culture and strong relationships with scientists and clinicians at the CU Anschutz Medical Campus as critical to the company's success.
Neurexis Therapeutics relies on innovation to address a substantial unmet medical need:damage to the brain resulting from loss of blood flow during stroke, cardiac arrest, and other events. The company's goal is to advance a neuroprotective drug that prevents impairment and improves patients' lives. Less than a year since forming, Neurexis is propelling forward with progress.
Z Biotech is a leading biotech company providing the most advanced microarray products and quality services for glycomics research. They contribute leading carbohydrate products and services to biotech and pharmaceutical companies and research institutes worldwide. Through integrity of research, team selfawareness and their community, Z Biotech has made strides in 2020.
Alpha Omega Alpha Honor Medical Society
Alpha Omega Alpha Honor Medical Society (AΩA) aims to improve the medical profession and care for all through education, teaching, leadership, humanism, and community service. AΩA is the nation’s only interdisciplinary honor medical society providing $2 million annually in grants, fellowships, awards, and programs to medical faculty and students, and mid-career physicians.
IMD Path is an integrated Molecular Diagnostics Laboratory with enabling pathology and empowering oncology offering state-of-the-art technology and testing capabilities. With out of the box creative design, and a strong culture, IMD Path focuses on the individual contribution to the overall mission to deliver best in class, quality, and accurate testing.
ClinImmune Labs is a network of innovators and dedicated visionaries that specialize in cell therapy and gene therapy. A pioneer in stem cell therapy, ClinImmune recognizes their team brings a unique ecosystem to the work that pushes successes to the next level, saving more patients lives across several countries and reaching more advances in scientific discoveries.
ArtisanBio Cell Therapies
ArtisanBio creates customized cell engineering solutions to solve the most challenging problems in human health applications. By leveraging rapid advances in DNA reading and writing technologies at the interface of engineering and biology, Artisan delivers more efficacious and safe cell products to the market. Their team is built on an environment of innovation and talent.
The DARTNet Institute
The DARTNet Institute (DI) has facilitated partnerships between practice-based research networks, academic health centers, clinicians, and patients. The institute leverages existing electronic data and the expansion of patient or staff-reported data for research, quality improvement, and safety.
Avidity finds creative fuel at Fitzsimons Innovation Community. An expert in bioluminescent technologies, the company develops molecular affinity tools for connecting molecules. Avidity products are sold worldwide, including to research institutions investigating treatments for COVID-19.
Looking for new points of view, leaders at Boulder-based Biodesix made recruiting diverse executives a priority.
Three women now make up half of the company’s C-level team. To accelerate growth, the women made tough decisions about major changes at the company, which focuses on blood-based diagnostics to help doctors evaluate and treat non-small cell lung cancer.
Colorado attracts biotech pioneers. Leaders of i2 Pharmaceuticals say the state's innovation environment allows smart, motivated people to make a name for themselves. The Boulder company works with major drug manufacturers for support solving the drug discovery puzzle.
AlloSource® started as a local, Denver-based tissue bank and has grown into one of the largest allograft providers in the country.
Today, AlloSource’s work focuses on regenerative medicine and the potential power of cellular technologies, making the company the world’s largest processor of cellular allografts for transplant and the leading provider of skin allografts for burn survivors.